In addition, we identified several miRNA and transcription factors associated with HSP90AA1 and CDK2 and explored the potential of HSP90AA1 and CDK2 as therapeutic targets for NSCLC, thus providing a direction and scientific basis for future studies of mechanisms of action. This evidence concerns the gene HSP90AA1 and non-small cell lung carcinoma.